NHU(002001)2024-04-30 10:39Group 1: Company Performance and Projects - The company plans to achieve normal production and sales of the 150,000 tons solid methionine project in 2024, and the 180,000 tons liquid methionine project in partnership with Sinopec is progressing steadily, expected to be completed by the end of the year [3][8]. - The company has consistently focused on cash dividends to return profits to investors since its listing and will continue to do so in the future [3]. - The company aims to enhance its product competitiveness through innovation and the development of new products [3][6]. Group 2: Market and Competition - The company acknowledges the existence of competition in the industry and emphasizes its commitment to innovation-driven growth to enhance its overall competitiveness [3][6]. - The vitamin market is currently experiencing a supply surplus, leading to intense competition, with the company focusing on optimizing its production processes to maintain competitiveness [6][8]. - The company is actively expanding its international presence, having established overseas sales companies in regions such as Hong Kong, Singapore, Germany, Mexico, and Brazil [6][8]. Group 3: Financial Outlook and Strategy - The company has set a target for production value and profit growth in 2024, aligning with its operational philosophy of market expansion, development, management enhancement, and risk prevention [3][6]. - The company is committed to maintaining a focus on high-quality development and optimizing resource allocation to support international market expansion [7][8]. - The company plans to continue its investment in high-value-added products and smart manufacturing to improve production efficiency and reduce costs [6][8].